patients carrying normal version enzyme immune nitroglycerin effects prolonged use nitro lead drug tolerance return chest pain researchers found alda1 reversed tolerance rats animals administered nitro induced cardiac event question remains laboratory results replicated humans study leader daria mochly rosen pharmacologist stanford university school medicine believes alda1 far reaching applications cardiac patients looking people aldh2 mutation identify chronic diseases associated not having enzyme function says notes aldh2 active cells body function critical eliminating toxic products organs life toxin accumulation offset alda1 helping prevent diseases old age risk example reduced alda1 help clear harmful molecules implicated promoting plaque formation brain mochly